SGMW to put first mobile nucleic acid sampling vehicles onto market in August

Shanghai (Gasgoo)- SAIC-GM-Wuling (“SGMW”), General Motors' joint venture with Chinese partners SAIC Motor and Guangxi Automobile Group, announced on July 26 its first mobile nucleic acid sampling vehicles would be put into use in August in Shanghai, aiming to further facilitate the epidemic prevention and control works.

The automaker said the new mobile nucleic acid sampling vehicle would come with a two-seater or four-seater cockpit layouts with a service capacity of taking around 17,000 nucleic acid samples. Besides, the vehicle is equipped with an extensible sampling window to improve operation efficiency under contingencies.

Photo credit: SGMW

The new type of vehicle will shift the nucleic acid testing mode from “people to site” to “ site to people”. To satisfy the testing demands of students, seniors, and other special-need groups, the vehicles can directly move to where the residents live for rapid sampling.

As an automaker, SGMW has made lots of crossover contributions to epidemic prevention and control, such as developing mobile temperature-measuring vehicles and producing masks.

The company on July 14 announced its foray into the HEV (hybrid electric vehicle) field by virtue of its advantages in the integrated ecosystem of NEV core component supply chain and the in-house development capability of batteries, electric control units, and chips.

In the second half of 2022, SGMW plans to roll out the HEV versions of the Wuling Victory and the Wuling Asta, which are expected to carry a hybrid system with a 2.0-liter engine.